Pattern of psychotropic medication use over two decades in Australian women

Australian and New Zealand Journal of Psychiatry

Volumn 51, Issue 12, 2017, Pages 1212-1219

  Stuart, Amanda L ^a   Mohebbi, Mohammadreza ^a   Pasco, Julie A ^a,b,c   Quirk, Shae E ^d   Brennan Olsen, Sharon L ^a,b,e   Berk, Michael ^a,f,g   Williams, Lana J ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c BARWON HEALTH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^f FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^g THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

Author keywords

antidepressants; drug utilisation; population; prescribing; Psychotropics

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIAN; COHORT ANALYSIS; CONTROLLED STUDY; DRUG USE; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PRESCRIPTION; PREVALENCE; QUALITY OF LIFE; SELF REPORT; TREND STUDY; AGE; AUSTRALIA; MIDDLE AGED; YOUNG ADULT;

ADULT; AGE FACTORS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; AUSTRALIA; COHORT STUDIES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MIDDLE AGED; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 85035141000     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867417704056     Document Type: Article

References (24)

1. Alexander GC, Gallagher SA, Mascola A. (2011) Increasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiology and Drug Safety 20: 177–184.
2. Chen Y, Kelton CM, Jing Y. (2008) Utilization, price, and spending trends for antidepressants in the US Medicaid Program. Research in Social and Administrative Pharmacy 4: 244–257.
3. Exeter D, Robinson E, Wheeler A, (2009) Antidepressant dispensing trends in New Zealand between 2004 and 2007. Australian and New Zealand Journal of Psychiatry 43: 1131–1140.
4. Han B, Compton WM, Mojtabai R. (2016) Trends in receipt of mental health treatments among adults in the United States, 2008–2013. Journal of Clinical Psychiatry 77: 1365–1371.
5. Hollingworth SA, Siskind DJ, (2010) Anxiolytic, hypnotic and sedative medication use in Australia. Pharmacoepidemiology and Drug Safety 19: 280–288.
6. Hollingworth SA, Burgess PM, Whiteford HA, (2010a) Affective and anxiety disorders: Prevalence, treatment and antidepressant medication use. Australian and New Zealand Journal of Psychiatry 44: 513–519.
7. Hollingworth SA, Siskind DJ, Nissen LM. (2010b) Patterns of antipsychotic medication use in Australia 2002–2007. Australian and New Zealand Journal of Psychiatry 44: 372–377.
8. Ilyas S, Moncrieff J, (2012) Trends in prescriptions and costs of drugs for mental disorders in England, 1998–2010. British Journal of Psychiatry 200: 393–398.
9. Islam MM, Conigrave KM, Day CA. (2014) Twenty-year trends in benzodiazepine dispensing in the Australian population. Internal Medicine Journal 44: 57–64.
10. Jorm AF, (2014) Why hasn’t the mental health of Australians improved? The need for a national prevention strategy. Australian and New Zealand Journal of Psychiatry 48: 795–801.
11. Jorm AF, Reavley NJ, (2012) Changes in psychological distress in Australian adults between 1995 and 2011. Australian and New Zealand Journal of Psychiatry 46: 352–356.
12. Mcmanus P, Mant A, Mitchell PB. (2000) Recent trends in the use of antidepressant drugs in Australia, 1990–1998. Medical Journal of Australia 173: 458–461.
13. MIMs Australia. April 2017. MIMs online. Available at: www.mimsonline.com.au (accessed April 2016).
14. Mojtabai R, (2008) Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychotherapy and Psychosomatics 77: 83–92.
15. Mojtabai R, Olfson M, (2010) National trends in psychotropic medication polypharmacy in office-based psychiatry. Archives of General Psychiatry 67: 26–36.
16. Olfson M, Marcus SC, (2009) National patterns in antidepressant medication treatment. Archives of General Psychiatry 66: 848–856.
17. Olfson M, Blanco C, Marcus SC, (2016) Treatment of adult depression in the United States. JAMA Internal Medicine 176: 1482–1491.
18. Pasco JA, Nicholson GC, Kotowicz MA, (2012) Cohort profile: Geelong osteoporosis study. International Journal of Epidemiology 41: 1565–1575.
19. Paulose-Ram R, Safran MA, Jonas BS. (2007) Trends in psychotropic medication use among U.S. adults. Pharmacoepidemiology and Drug Safety 16: 560–570.
20. Smith AJ, Sketris I, Cooke C. (2008) A comparison of antidepressant use in Nova Scotia, Canada and Australia. Pharmacoepidemiology and Drug Safety 17: 697–706.
21. Stephenson CP, Karanges E, Mcgregor IS, (2013) Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Australian and New Zealand Journal of Psychiatry 47: 74–87.
22. Verdoux H, Tournier M, Begaud B, (2010) Antipsychotic prescribing trends: A review of pharmaco-epidemiological studies. Acta Psychiatrica Scandinavica 121: 4–10.
23. Williams L, Jacka F, Pasco J. (2010) The prevalence of mood and anxiety disorders in Australian women. Australasian Psychiatry 18: 250–255.
24. Zuvekas SH, (2005) Prescription drugs and the changing patterns of treatment for mental disorders, 1996–2001. Health Affairs 24: 195–205.